These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6427462)

  • 21. Comparison of gold levels and distribution in guinea pig serum.
    Kamel H; Brown DH; Ottaway JM; Smith WE; Cottney J; Lewis AJ
    Arthritis Rheum; 1978 May; 21(4):441-6. PubMed ID: 418787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antirheumatic drug disodium aurothiomalate inhibits CD4+ T cell recognition of peptides containing two or more cysteine residues.
    Griem P; Takahashi K; Kalbacher H; Gleichmann E
    J Immunol; 1995 Aug; 155(3):1575-87. PubMed ID: 7543525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro distribution of gold in serum proteins after incubation of sodium aurothiomalate and auranofin with human blood and its pharmacological significance.
    Iqbal MS; Taqi SG; Arif M; Wasim M; Sher M
    Biol Trace Elem Res; 2009 Sep; 130(3):204-9. PubMed ID: 19194667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in the characterization of gold drugs.
    Grootveld MC; Razi MT; Sadler PJ
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():5-16. PubMed ID: 6432413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience and rationale of monitoring plasma levels of gold in rheumatoid arthritis.
    Lorber A
    Agents Actions Suppl; 1981; 8():539-73. PubMed ID: 6781239
    [No Abstract]   [Full Text] [Related]  

  • 26. Aurothiomalate-Based Drugs as Potentially Novel Agents Against Leishmania major: A Mini Review.
    Davoodi A; Eslami S; Fakhar M; Aazadbakht M; Montazeri M; Khoshvishkaie E; Keighobadi M
    Acta Parasitol; 2022 Jun; 67(2):640-647. PubMed ID: 35380401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA].
    Minami M; Kaneda K
    Ryumachi; 1995 Oct; 35(5):780-91. PubMed ID: 8594657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excretion of gold into human breast milk.
    Ostensen M; Skavdal K; Myklebust G; Tomassen Y; Aarbakke J
    Eur J Clin Pharmacol; 1986; 31(2):251-2. PubMed ID: 3100315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of 'free' gold in patients receiving disodium aurothiomalate and the association of high free to total gold levels with toxicity.
    Heath MJ
    Ann Rheum Dis; 1988 Jan; 47(1):18-21. PubMed ID: 3125798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Another anaphylactic reaction after gold (aurothiomalate) injection.
    Neustadt DH
    J Rheumatol; 1995 Jan; 22(1):190. PubMed ID: 7699674
    [No Abstract]   [Full Text] [Related]  

  • 32. Gold concentrations in blood fractions of patients with rheumatoid arthritis treated with Myocrisin.
    Egila J; Littlejohn D; Smith WE; Sturrock RD
    J Pharm Biomed Anal; 1992 Sep; 10(9):639-44. PubMed ID: 1286129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of low doses of sodium aurothiomalate in the treatment of rheumatoid arthritis. Current trends in basic therapy].
    Bianucci G; Maddali Bongi S; Cencetti A; Curradi C
    Clin Ter; 1996 Dec; 147(12):609-20. PubMed ID: 9296920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aurothiomalate inhibits COX-2 expression in chondrocytes and in human cartilage possibly through its effects on COX-2 mRNA stability.
    Nieminen R; Vuolteenaho K; Riutta A; Kankaanranta H; van der Kraan PM; Moilanen T; Moilanen E
    Eur J Pharmacol; 2008 Jun; 587(1-3):309-16. PubMed ID: 18448096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc ions antagonize the inhibitory effect of aurothiomalate on glucocorticoid receptor function at physiological concentrations.
    Tanaka H; Makino Y; Dahlman-Wright K; Gustafsson JA; Okamoto K; Makino I; Wright KD [corrected to Dahlman-Wright K]
    Mol Pharmacol; 1995 Nov; 48(5):938-45. PubMed ID: 7476925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of gold in the rat following a single administration of sodium aurothiomalate: mathematical analysis of serum and organ concentrations.
    Mason R; Kingsford M
    Biochem Pharmacol; 1979 Dec; 28(24):3637-41. PubMed ID: 119544
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro binding and pharmacokinetics of gold salts in plasma proteins and chelating agents.
    Biggs DF; Boland DM; Davis P; Wakaruk J
    J Rheumatol Suppl; 1979; 5():68-73. PubMed ID: 114650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Free' plasma gold in rheumatoid patients undergoing chrysotherapy [proceedings].
    Danpure CJ
    J Physiol; 1977 May; 267(1):25P-26P. PubMed ID: 406384
    [No Abstract]   [Full Text] [Related]  

  • 39. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 40. Preparation of a gelatin-binding conjugate containing gold thiomalate.
    Brown RA; More J; Ejim OS
    Arzneimittelforschung; 1993 Jun; 43(6):682-5. PubMed ID: 8352823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.